The company said its Board appointed Flavia Pease as Class II director and Tim Stonesifer as Class I director on January 18, 2024, effective January 18, 2024.

1. 01

   The company said its Board appointed Flavia Pease as Class II director and Tim Stonesifer as Class I director on January 18, 2024, effective January 18, 2024.

2. 02

   The company said Pease will stand for election by stockholders at the 2024 Annual Meeting of Stockholders, and Stonesifer at the 2026 Annual Meeting. Both were named to the Audit Committee effective March 1, 2024.

3. 03

   The company said Pease has been Chief Financial Officer of Charles River Laboratories since May 2022, and Stonesifer has been Chief Financial Officer of Alcon Inc. since April 2019. Both will receive cash and equity compensation under the company's non-employee director compensation program.

4. 04

   The company said Shacey Petrovic and Corinne H. Nevinny notified it that they will step down from the Board effective as of the January 17, 2024 2024 Annual Meeting. The company said their decisions did not involve any disagreement with other Board members or management.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.